An announcement www.nephjc.com/news/2025/11... #NephJC @kidneyboy.bsky.social and moi hand over the @nephjc.bsky.social reigns to @nephroseeker.medsky.social & @brianrifkin.bsky.social

These are not FDA approved yet - this trial + VISIONARY for Sibeprenlimab will lead to approval soon Approved = Nefecon Atrasentan Sparsentan Iptacopan (I think) #Nephjc

Excellent comparison of completed IgAN studies from today's @CSNSCN webinar from Kevin Yau #NephSky

Late breakers that included children: ✅Setanaxib in Alport (12+) Late breakers that did NOT include children: 🚫Atacicept in IgAN 🚫CONFIDENCE 🚫PISCES: Fish oil in Dialysis 🚫LIBERATE-D 🚫balcinrenone + dapa 🚫Obintuzumab in lupus nephritis 🚫Sibeprenlimab in IgA 🚫MIL62 in membranous +more #KidneyWk

Peds nephrons at #ASN2025 #KidneyWk , participate in @aspneph.bsky.social scavenger hunt and win prizes! Download ASPNGo App!! @nefronica-2rair.bsky.social @coleaugust.bsky.social

Clinical importance of prediction tools: 🔬 The prediction tool was developed with the data from 4000 people in multinational and multiracial cohorts and can be generalized to all. Do you routinely use prediction tools with IgAN patients? #NephJC

Treatment in children: 👶💉 Management is based on RAS blockade, salt restriction, and blood pressure control. Glucocorticoids are used in those with persistent proteinuria or high-risk features, sometimes combined with cyclophosphamide in severe cases. #NephJC

🤔 How often is end-stage kidney disease in patients with MCD/ FSGS? #NephSky #MedSky @brianrifkin.bsky.social dissected the conclusions from the RaDar study in this #NephJCshorts *the original article from @asnpublications.bsky.social www.nephjc.com/news/nephjc-...

Everything said and done - although eGFR diff may signal ominous outcomes - practically speaking following one eGFR over time and seeing the eGFR fall predicts outcomes better than anything else ! And that’s what would be feasible across economies ! #NephJC

The #NephJC editorial team knows that plenty of papers deserve attention between our bi-monthly, full-length discussions ✨Enter #NephJCShorts - quick hits with a critical eye 🦅 on high-impact reads www.nephjc.com/news/nephjc-... #MedSky #NephSky

From Rivka Galchen’s article in @newyorker.com: “The kidney, a tremendously under-celebrated organ, basically does four-dimensional sudoku with ions.” And that’s how I’m going to explain it from now on.

I do the same with any agent. Treat for 2 years then try off. If relapse, then another 2 years. #NephJc I don’t think there’s great data. Just seems a good balance of risk.

Congrats to all the @asnkidney.bsky.social lifetime and mid-career awardees! @ksusztak.bsky.social @genetickidneydoc.bsky.social @shinamenon.bsky.social @michellejtx.bsky.social and everyone else!

DDAvP will increase VWF levels but in an uremic mileu does it really help towards platelets adhesion? #NephJC

Would make sense to check VWF otherwise hard to prove anything unless they compare with their previous institutional cohort # NephJC

T0c So how does DDAVP skip the bleeding drama? 🩸 🧬 Desmopressin → triggers cAMP → exocytosis of vWF & FVIII from endothelium ➡️ Boosts platelet adhesion in uremic dysfunction ⏱️ Onset: 30–90 min ⏳ Duration: 4–8 h #NephJC

We used to do pre procedure DDAVP for abnormal PFA’s, mostly in CKD/ uremic kids # NephJC

Peds Nephrologist @texaschildrens.bsky.social No COI #NephJC

Join hosts Emily Zangla and Jordy Salcedo with moderators from four nephrology sessions at the 2025 Pediatric Academic Societies Conference in Honolulu, Hawaii. buff.ly/HdQWefG

Anyone seen membranous nephropathy( PLA2r neg) in pt with long standing Thal major, transfusion dependent? #NephSky #askrenal @askrenal.bsky.social

🚨 The ASPN Scavenger Hunt is almost here! 🗓 Launches April 25 – are you ready? ✅ Download the ASPN Go App now Complete tasks ➡ Win prizes! 🎁 Daily Yeti Cups + a grand prize Amazon Gift Card #ASPNHunt #ComingSoon buff.ly/br6ocqR

Attending #PAS2025 ? Fun way to engage with fellow nephrons through our ASPN Go App!!📱📲 #pedsneph #ASPNHunt @aspnr.bsky.social @nefronica-2rair.bsky.social @drm-sudha.bsky.social @sugarkro.bsky.social @asouth-neph.bsky.social

Skeleton Key Group still going strong with their 37th electrolyte case www.renalfellow.org/2025/03/19/s...

#NephMadness party ✅ Were there cookies? ❌ Was it a great discussion? ✅✅ Some were resistant, some needed incremental push, lot of disasters and conflicts, but finally convinced!!🤣🤣🤣 @nephmadness.bsky.social Genetics in FSGS 🏆

After listening to this podcast, i might be a convert now! Genetic counseling might be more important than sending genetic testing!! @nephmadness.bsky.social #NephMadness

Love the science behind anti-nephrin Ab but 35% AA have one risk allele for APOL-1 & 14% have 2 risk alleles! Those r huge number of people predisposed to AMKD! IMO, it will be the winner , it has to🤣 @nephmadness.bsky.social

Are you a patient with Alport syndrome? The 2025 In-Person Alport Connect meeting will be in Chicago on July 19-20th. Child and teen programming available. See you there! alportsyndrome.org/for-patients...

On it! @nephmadness.bsky.social party Tuesday! Reading in process!! #NephMadness #NephSky

APOL1 versus Anti-nephrin!! Loving it #NephMadness

So excited for this topic!! #NephMadness 2025

Happy #NephMadness Day! The 8 regions of #NephMadness 2025 have been revealed on the #AJKDBlog. If you're a #NephMadnessNewbie, we explain everything here: buff.ly/DCZDRfN Looking forward to the fun and learning with all of you!

@louiseoni.bsky.social on Lupus Nephritis to close out this amazing session. #IPNA2025 Glom Dis update.

Dr Hugh McCarthy: What if we did genetic testing on all children with ESKD? Chinese study shows hit rate of 46.7% #IPNA2025 pubmed.ncbi.nlm.nih.gov/39363361/

Dr Julien Hogan presents results of RCT in children with FR nephrotic syndrome treated with Rituximab +/- IVIG. Result: Addition of IVIG showed no benefit on relapse free survival. #IPNA2025

Can’t even!! ☀️🌞🌻❄️☃️

Was great to be back! #NephJC after 40 min, figured out deck.blue :-)) Thanks @verner-venegas.bsky.social

The current study brings to light that aldosterone production, independent of renin and AG II, is a continuum with potentially many people below the threshold of the classic phenotypic findings seen in primary aldosteronism. #NephJC

Similar to SPRINT/ESPRIT/BPROAD, in peds nephrology we may target lower than normotension (ie less than 95%tile). In one using CkID dataset there was a differentiation between glomerular vs nonglomerular #NephJC www.ahajournals.org/doi/10.1161/...

Shweta Shah, Peds nephrologist at Texas Children’s Houston. No COI, except that I have been MIA for a while 😔😔 #NephJC

www.kireportscommunity.org/post/unlocki... @ghobby.bsky.social @kireports.bsky.social

Patient and Healthcare Provider Perspectives on Showering for Patients With Hemodialysis Central Venous Catheters: A Survey Study https://bit.ly/3BV51WQ #OpenAccess

Why should it always be snow MAN!! 🤣 #Houstonsnow #coldweather ☃️⛄️❄️🌹

Throwback to med school days! Enjoying reading through my favorite Guyton textbook of physiology.

Had a lovely 12 hr vacation @Houston airport, walked around 3 terminals, changed gates 4x and now returning home only to do it again tomorrow!! #wintertravels #holidaytravels #torontoherewecome

We are excited to welcome our new incoming fellows 🤗🤗Dr. Olubunmi “Bunmi” Fatoki and Dr. Joshua Lipsitz to our renal family here at Texas Children’s -Baylor College of Medicine!! 🥳 A big congratulations to all those who matched into the peds neph community! 🥰❤️🫘 #nephsky #matchday #pedsneph

Starter pack specific for #PedNeph professionals. Hard to keep to with everyone joining so please let me know if you want to be added or see anyone missing! go.bsky.app/DEJdD5

1/ Hey #NephSky! Welcome to a 🆕 #skeetorial brought to you by @KIReports. Want more, check out the blog here: www.kireportscommunity.org/post/type-1-...

Nothing typically ruffles my feathers 🪶 But a peer to peer for a medication PA manages to do it!! 🤬😬 #medsky #nephsky

Sky is the limit! #skytorial Awesome as always @mchanmd.bsky.social